Your browser doesn't support javascript.
loading
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.
Kosiborod, Mikhail N; Bhatta, Meena; Davies, Melanie; Deanfield, John E; Garvey, W Timothy; Khalid, Usman; Kushner, Robert; Rubino, Domenica M; Zeuthen, Niels; Verma, Subodh.
Afiliação
  • Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Bhatta M; Novo Nordisk A/S, Søborg, Denmark.
  • Davies M; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Deanfield JE; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Garvey WT; Institute of Cardiovascular Science, University College London, London, UK.
  • Khalid U; Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Kushner R; Novo Nordisk A/S, Søborg, Denmark.
  • Rubino DM; Division of Endocrinology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Zeuthen N; Washington Center for Weight Management and Research, Arlington, Virginia, USA.
  • Verma S; Novo Nordisk A/S, Søborg, Denmark.
Diabetes Obes Metab ; 25(2): 468-478, 2023 02.
Article em En | MEDLINE | ID: mdl-36200477
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insulinas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insulinas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article